| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/03/2011 | CA2341503C Probiotic, lactic acid-producing bacteria and uses thereof |
| 05/03/2011 | CA2283680C Calcium phosphopeptide complexes |
| 05/03/2011 | CA2246297C Use of an anti-human tnf-alpha monoclonal antibody in the manufacture of a therapeutic formulation for treating a thrombotic disorder |
| 05/03/2011 | CA2174961C Desferrioxamine oral delivery system |
| 04/28/2011 | WO2011050357A2 Protein arginine deiminase inhibitors as novel therapeutics for rheumatoid arthritis and cancer |
| 04/28/2011 | WO2011050206A2 Compositions and methods for the treatment of sinonasal disorders |
| 04/28/2011 | WO2011050178A2 Targeted prdm gene or protein modulation therapeutic agents |
| 04/28/2011 | WO2011050039A2 Modular functional peptides for the intracellular delivery of nanoparticles |
| 04/28/2011 | WO2011050018A1 Compositions and methods for controlling pupil dilation comprising phentolamine |
| 04/28/2011 | WO2011049972A1 Nanoparticles for drug delivery |
| 04/28/2011 | WO2011049960A2 Compositions and methods for the treatment of sinonasal disorders |
| 04/28/2011 | WO2011049958A2 Modulation of gel temperature of poloxamer-containing formulations |
| 04/28/2011 | WO2011049954A2 Compositions comprising wnt modulators or neurotoxins for the treatment of otic disorders |
| 04/28/2011 | WO2011049943A1 Method and kit for gastro-intestinal cleansing |
| 04/28/2011 | WO2011049309A2 Pharmaceutical composition with both immediate and extended release characteristics |
| 04/28/2011 | WO2011049256A1 Photosensitizer/metal nanoparticle charge complex and composition containing the complex for photodynamic therapy or diagnosis |
| 04/28/2011 | WO2011049247A1 Thickening or gelling agent for oily raw materials |
| 04/28/2011 | WO2011049191A1 Pharmaceutical composition for oral administration |
| 04/28/2011 | WO2011049122A1 Pravastatin sodium tablet rapidly disintegrating in oral cavity and method for producing same |
| 04/28/2011 | WO2011049059A1 Composition comprising rna-enclosing carrier |
| 04/28/2011 | WO2011049058A1 Water-based paste containing diclofenac sodium |
| 04/28/2011 | WO2011049042A1 Block copolymer for intraperitoneal administration containing anti-cancer agent, micelle preparation, and cancer therapeutic agent comprising the micelle preparation as active ingredient |
| 04/28/2011 | WO2011049038A1 Transdermally absorbable donepezil-containing preparation |
| 04/28/2011 | WO2011049036A1 Low-molecular drug-containing nanoparticle |
| 04/28/2011 | WO2011048598A1 Compositions and methods for treating aspergillosis |
| 04/28/2011 | WO2011048040A1 Method and formulation for the control of parasites |
| 04/28/2011 | WO2011047486A1 Biodegradable thermoresponsive hydrogels |
| 04/28/2011 | WO2011026824A3 Novel diagnostic agents for the non-invasive in vivo imaging of aminopeptidase n (apn/cd13) |
| 04/28/2011 | WO2011026122A3 B7-h4 fusion proteins and methods of use thereof |
| 04/28/2011 | WO2011020783A3 Targeted immunoconjugates |
| 04/28/2011 | WO2011005864A3 Ophtalmic ethyleneoxide butyleneoxide block copolymer compositions |
| 04/28/2011 | WO2011004398A3 Preservatives from chitin derivatives |
| 04/28/2011 | WO2010141806A3 Compositions and methods for delivery of materials |
| 04/28/2011 | WO2010140869A3 Complex, multilayer using the same, and device coated with the multilayer |
| 04/28/2011 | WO2010135736A3 Application and uses of prg4 and therapeutic modulation thereof |
| 04/28/2011 | WO2010119384A3 A medicinal cream made using mometasone furoate, and chitosan, and a process to make the same |
| 04/28/2011 | WO2010117873A3 Progesterone solutions for increased bioavailability |
| 04/28/2011 | WO2010089128A3 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
| 04/28/2011 | WO2009069002A3 Low dose colony stimulating factors to treat amyloidosis |
| 04/28/2011 | US20110098464 Cellulose interpolymers and methods of oxidation |
| 04/28/2011 | US20110098366 Pharmaceutical Preparation in Containers that are Pervious to Water Vapor and Have Improved Stability |
| 04/28/2011 | US20110098365 Salt product |
| 04/28/2011 | US20110098364 Novel inverse latices based on fatty alcohol ethers, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising |
| 04/28/2011 | US20110098344 Drug carrier |
| 04/28/2011 | US20110097406 Methods and compositions for retaining ecm materials in hydrogels |
| 04/28/2011 | US20110097404 Tamper-resistant oral opioid agonist formulations |
| 04/28/2011 | US20110097399 Fast dissolving/disintegrating coating compositions |
| 04/28/2011 | US20110097398 Reduction of cross-linking gelatin in gelatin capsules |
| 04/28/2011 | US20110097392 Antibody bound synthetic vesicle containing molecules for deliver to central and peripheral nervous system cells |
| 04/28/2011 | US20110097385 Delivery System for Drug and Cell Therapy |
| 04/28/2011 | US20110097379 Directed stem cell recruitment |
| 04/28/2011 | US20110097306 Oral formulations of cladribine |
| 04/28/2011 | US20110097299 Swellable and degradable microspheres |
| 04/28/2011 | US20110097296 Novel Pyran Derivatives, Their Preparation and Use Thereof in Perfumery |
| 04/28/2011 | US20110097280 Intracorporeal Medicaments for Photodynamic Treatment of Disease |
| 04/28/2011 | CA2778533A1 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
| 04/28/2011 | CA2778472A1 Compositions and methods for controlling pupil dilation comprising phentolamine |
| 04/28/2011 | CA2778411A1 Pharmaceutical composition for oral administration |
| 04/28/2011 | CA2778176A1 Dual variable domain immunoglobulins and uses thereof |
| 04/28/2011 | CA2778103A1 Donepezil-containing transdermal absorption formulation |
| 04/28/2011 | CA2778009A1 Aqueous patches containing diclofenac sodium |
| 04/28/2011 | CA2774032A1 Anti-gcc antibody molecules and related compositions and methods |
| 04/27/2011 | EP2314711A1 Methods for expression and purification of immunotoxins |
| 04/27/2011 | EP2314640A1 Acrylic hydrogels with pendant cyclodextrins, preparation method thereof and use of same as release systems and contact lens components |
| 04/27/2011 | EP2314609A1 Metastin derivative and use thereof |
| 04/27/2011 | EP2314327A1 Injectable cross-linked polymeric preparations and uses thereof |
| 04/27/2011 | EP2314321A1 Formulations comprising antisense nucleotides to connexins |
| 04/27/2011 | EP2314320A2 Method for shielding functional sites or epitopes on proteins |
| 04/27/2011 | EP2314319A1 Colon Cleansing Compositions |
| 04/27/2011 | EP2314293A1 Implantable device containing resorbable matrix material and rapamycin for preventing or treating vasuloproliferative diseases |
| 04/27/2011 | EP2314288A1 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 04/27/2011 | EP2314272A1 Stable hydroalcoholic compositions |
| 04/27/2011 | EP2313457A2 Peptide-polymer conjugates |
| 04/27/2011 | EP2313423A2 Nucleic acid comprising zwitterionic nucleotides |
| 04/27/2011 | EP2313340A2 Dilute aqueous peracid solutions and stabilization method |
| 04/27/2011 | EP2313116A1 Improved bacterial polysaccharide-polypeptide conjugate compositions |
| 04/27/2011 | EP2313115A2 Polymeric delivery systems for active agents |
| 04/27/2011 | EP2313114A2 A drug powder for inhalation administration and a process thereof |
| 04/27/2011 | EP2313111A1 Toll-like receptor agonist formulations and their use |
| 04/27/2011 | EP2313104A1 Thiolated chitosan gel |
| 04/27/2011 | EP2313101A1 Functional micelles for hard tissue targeted delivery of chemicals |
| 04/27/2011 | EP2313093A2 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 04/27/2011 | EP2313087A1 Pharmaceutical dosage form for immediate release of an indolinone derivative |
| 04/27/2011 | EP2313054A2 Foaming skincare cream |
| 04/27/2011 | EP1930436B1 Vector for delivering target substance into nucleus or cell |
| 04/27/2011 | EP1809330B1 Compositions for reducing toxicity of cisplatin, carboplatin, and oxaliplatin |
| 04/27/2011 | EP1796624B1 Use of a viscoelastic composition for treating increased intraocular pressure |
| 04/27/2011 | EP1578325B1 Stable topical drug delivery compositions |
| 04/27/2011 | EP1554315B1 Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes |
| 04/27/2011 | EP1551977B1 Selective, local activation of members of the tnf ligand family of systemically inactive non-antibody tnf ligand fusion proteins |
| 04/27/2011 | EP1307194B2 Fentanyl composition for nasal administration |
| 04/27/2011 | EP1303541B1 Compositions containing metronidazole |
| 04/27/2011 | CN201806956U Bone joining cataplasm patch |
| 04/27/2011 | CN1845995B Chimeric antigens for breaking host tolerance to foreign antigens |
| 04/27/2011 | CN1639317B Probiotic lactobacillus salivarius strains |
| 04/27/2011 | CN1617708B Taste masked aqueous liquid pharmaceutical composition |
| 04/27/2011 | CN102037058A Docetaxel polymer derivative, method for producing same and use of same |
| 04/27/2011 | CN102037005A New optically pure compounds for improved therapeutic efficiency |
| 04/27/2011 | CN102036689A Identification of micro-RNAs involved in neuromuscular synapse maintenance and regeneration |
| 04/27/2011 | CN102036687A Conjugates of a cholinesterase moiety and a polymer |